Trials / Completed
CompletedNCT03940469
Dexmedetomidine Versus Dexamethasone With Levobupivacaine in Interscalene Block
Comparison Between Dexmedetomidine Versus Dexamethasone With Levobupivacaine in Ultrasound Guided Interscalene Block During Shoulder Arthroscopy: A Randomized Controlled Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Menoufia University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The investigators compared between dexamethasone and dexmedetomidine when added to levobupivacaine in the quality and duration of ultrasound-guided interscalene block during shoulder arthroscopy.
Detailed description
Sixty patients were enrolled and divided into three groups 20 each, Group C received 35ml levobupivacaine+2ml normal saline under ultrasound guided interscalene block. Group H received 35ml levobupivacaine+8mg dexamethasone under ultrasound guided interscalene block. Group D received 35ml levobupivacaine+100umg dexmedetomidine+1ml normal saline. The primary outcome was the postoperative pain which was assessed by Visual analog score(VAS), the secondary outcomes were the onset and duration of sensory and motor block, the total amount of analgesic requirement, and blood cortisol level.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Saline | 2 ml normal saline |
| DRUG | Dexamethasone Injection | 8 mg dexamethasone |
| DRUG | Dexmedetomidine Hydrochloride | 100 microgram dexmedetomidine |
Timeline
- Start date
- 2016-07-03
- Primary completion
- 2019-01-01
- Completion
- 2019-01-01
- First posted
- 2019-05-07
- Last updated
- 2019-05-07
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03940469. Inclusion in this directory is not an endorsement.